Accelerate Diagnostics Future Growth
Future criteria checks 1/6
Accelerate Diagnostics is forecast to grow earnings and revenue by 19.7% and 10.5% per annum respectively while EPS is expected to grow by 44.2% per annum.
Key information
19.7%
Earnings growth rate
44.2%
EPS growth rate
Medical Equipment earnings growth | 22.1% |
Revenue growth rate | 10.5% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 10 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 14 | -44 | N/A | N/A | 1 |
12/31/2024 | 12 | -51 | N/A | N/A | 1 |
3/31/2024 | 12 | -62 | -37 | -35 | N/A |
12/31/2023 | 12 | -62 | -41 | -40 | N/A |
9/30/2023 | 12 | -63 | -43 | -42 | N/A |
6/30/2023 | 12 | -80 | -48 | -47 | N/A |
3/31/2023 | 13 | -66 | -50 | -49 | N/A |
12/31/2022 | 13 | -62 | -49 | -49 | N/A |
9/30/2022 | 13 | -71 | -52 | -51 | N/A |
6/30/2022 | 13 | -64 | -51 | -50 | N/A |
3/31/2022 | 12 | -67 | -48 | -47 | N/A |
12/31/2021 | 12 | -78 | -48 | -47 | N/A |
9/30/2021 | 12 | -74 | -46 | -46 | N/A |
6/30/2021 | 12 | -84 | -47 | -46 | N/A |
3/31/2021 | 11 | -81 | -47 | -46 | N/A |
12/31/2020 | 11 | -78 | -52 | -50 | N/A |
9/30/2020 | 12 | -81 | -55 | -54 | N/A |
6/30/2020 | 10 | -82 | -60 | -59 | N/A |
3/31/2020 | 10 | -84 | -64 | -63 | N/A |
12/31/2019 | 9 | -84 | -65 | -65 | N/A |
9/30/2019 | 8 | -85 | -66 | -65 | N/A |
6/30/2019 | 7 | -87 | -66 | -66 | N/A |
3/31/2019 | 7 | -89 | -71 | -71 | N/A |
12/31/2018 | 6 | -88 | -69 | -68 | N/A |
9/30/2018 | 6 | -82 | -68 | -67 | N/A |
6/30/2018 | 5 | -77 | -65 | -63 | N/A |
3/31/2018 | 4 | -71 | -60 | -56 | N/A |
12/31/2017 | 4 | -64 | N/A | -56 | N/A |
9/30/2017 | 2 | -64 | N/A | -55 | N/A |
6/30/2017 | 1 | -64 | N/A | -53 | N/A |
3/31/2017 | 1 | -65 | N/A | -56 | N/A |
12/31/2016 | 0 | -66 | N/A | -53 | N/A |
9/30/2016 | 0 | -63 | N/A | -50 | N/A |
6/30/2016 | 0 | -57 | N/A | -47 | N/A |
3/31/2016 | 0 | -52 | N/A | -41 | N/A |
12/31/2015 | 0 | -45 | N/A | -35 | N/A |
9/30/2015 | 0 | -41 | N/A | -30 | N/A |
6/30/2015 | 0 | -39 | N/A | -27 | N/A |
3/31/2015 | 0 | -35 | N/A | -22 | N/A |
12/31/2014 | 0 | -31 | N/A | -19 | N/A |
9/30/2014 | 0 | -27 | N/A | -17 | N/A |
6/30/2014 | 0 | -22 | N/A | -13 | N/A |
3/31/2014 | 0 | -18 | N/A | -11 | N/A |
12/31/2013 | 0 | -15 | N/A | -10 | N/A |
9/30/2013 | 0 | -13 | N/A | -11 | N/A |
6/30/2013 | 0 | -13 | N/A | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0H8E is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 0H8E is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 0H8E is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 0H8E's revenue (10.5% per year) is forecast to grow faster than the UK market (3.6% per year).
High Growth Revenue: 0H8E's revenue (10.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0H8E's Return on Equity is forecast to be high in 3 years time